AGO2 and ovarian carcinoma: Moreover, using Ago2‐RIP assay, we showed that immunoprecipitation with Ago2 antibody greatly pulled down both circATRNL1 and miR‐378 in ovarian cancer cells compared with immunoprecipitation with normal IgG antibody (Fig. 2F).